The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.129.6.738

The authors report on six patients with diazepam (Valium) toxicity. All showed symptoms of tremulousness, apprehension, insomnia, depression, and (later) ego-alien suicidal ideation. None had a history of previous psychiatric disorder, and all were taking greater than the maximum recommended dose of diazepam. Because the quality of the suicidal ideation in this syndrome differs from the usual indicators of suicidal intent, physicians should be alert to early symptoms of the syndrome and take measures to protect the patient against suicidal impulses.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.